Kura Oncology KURA
NASDAQ KURA
$10.86 +0.15 (+1.40%)
As of: Oct 1, 2026 · 10:49 AM EDT

Kura Oncology (KURA) Gross Margin (2025 - 2026)

Updated

Kura Oncology's Gross Margin came in at 98.84% for Q2 2026, down 1.16 percentage points from 100.00% a year earlier but up 0.27 percentage points from the prior quarter.

Analysis

Kura Oncology (KURA) Gross Margin (2025 - 2026) Analysis & Trends

Over the trailing twelve months to Jun 30, 2026, Kura Oncology reported Gross Margin of 88.09%; for FY2025, it was 99.92%, down 0.08 percentage points from FY2024.

  • Going back by year, Gross Margin was 100.00% in FY2024.
  • The five-year range for quarterly Gross Margin is 98.57% (Q1 2026) to 100.00% (Q2 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Gross Margin (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 68.19%
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 74.74%
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 73.54%
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn 78.02%
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn 83.60%
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 72.04%
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 79.76%
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 72.78%
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 85.33%
10 Kura Oncology 952.70 Mn 952.70 Mn 20.63 Mn 98.84%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 98.84%
Mar 31, 2026 98.57%
Jun 30, 2025 100.00%
Mar 31, 2025 100.00%
API Access

Kura Oncology Gross Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=gross-margin&ticker=KURA&period=max&api_key=YOUR_API_KEY